首页> 外国专利> Uses extrinsic calcium and the combined use remedy which consists of the calcium channel blocker the hypertension cure

Uses extrinsic calcium and the combined use remedy which consists of the calcium channel blocker the hypertension cure

机译:使用外在钙和由钙通道阻滞剂组成的综合疗法高血压治疗

摘要

PURPOSE: To obtain a medicinal agent having synergistic effect in hypertension therapy, by containing a calcium channel blocker and a calcium compound. CONSTITUTION: This medicinal agent, which contains a calcium channel blocker (e.g. nifedipine, verapamil) and a calcium compound (e.g. calcium carbonate), is obtained by formulating these active ingredients with a pharmaceuticallypermissible vehicle followed by pharmaceutical manufacturing by a conventional means. The amount of the calcium channel blocker to be formulated is such as to be enough to depress block pressure by 10-50%, that is, for the weight ratio of the calcium channel blocker to calcium compound (nifedipine/calcium carbonate) is (1:400) to (1:17), while verapamil/calcium carbonate (1:22) to (1:3). This medicinal agent is prepared into a form of tablets or capsules.
机译:目的:通过含有钙通道阻滞剂和钙化合物来获得在高血压治疗中具有协同作用的药物。组成:该药物包含钙通道阻滞剂(例如硝苯地平,维拉帕米)和钙化合物(例如碳酸钙),是通过将这些活性成分与药学上允许的载体配制在一起,然后通过常规方法进行制药而获得的。钙通道阻滞剂的配制量应足以使阻滞压力降低10-50%,即钙通道阻滞剂与钙化合物(硝苯地平/碳酸钙)的重量比为(1 :400)至(1:17),而维拉帕米/碳酸钙(1:22)至(1:3)。该药物被制成片剂或胶囊剂形式。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号